https://scholars.lib.ntu.edu.tw/handle/123456789/614132
標題: | Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer | 作者: | Mok T. Ladrera G. Srimuninnimit V. Sriuranpong V. CHONG-JEN YU Thongprasert S. Sandoval-Tan J. Lee J.S. Fuerte F. Shames D.S. Klughammer B. Truman M. Perez-Moreno P. Wu Y.-L. |
公開日期: | 2016 | 出版社: | Elsevier Ireland Ltd | 卷: | 98 | 起(迄)頁: | 1-8 | 來源出版物: | Lung Cancer | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966701371&doi=10.1016%2fj.lungcan.2016.04.023&partnerID=40&md5=a3db97d14c964d54437c5d15f284547d https://scholars.lib.ntu.edu.tw/handle/123456789/614132 |
ISSN: | 0169-5002 | DOI: | 10.1016/j.lungcan.2016.04.023 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。